Drostanolone Enanthate Raw Powder is a high-purity steroidal raw material commonly referred to as Dromostanolone Enanthate or Masteron Enanthate. AAS Raw Pharma supplies white or almost white crystalline Drostanolone Enanthate raw powder with a stated assay of 99.7% for qualified laboratory research, analytical testing, reference work, product development, and legally authorised manufacturing.
With a reported supply capacity of up to 100 kg per month, AAS Raw Pharma supports approved sample, small-volume, and bulk commercial enquiries. Customers can request current batch specifications, available quality documentation, packaging options, and a quotation based on the required quantity and destination.
Important product notice: This listing is for a bulk chemical raw material. It is not a finished medicine, injectable preparation, dietary supplement, or consumer product, and it is not intended for direct human or veterinary use. Drostanolone Enanthate raw powder is regulated or controlled in many jurisdictions. Buyers are responsible for ensuring that its purchase, possession, importation, handling, processing, and intended application are lawful.
Drostanolone Enanthate Raw Powder is the enanthate ester of drostanolone, which is also known as dromostanolone. Drostanolone is a synthetic compound related structurally to dihydrotestosterone. The enanthate ester distinguishes this substance from Drostanolone Propionate and gives it a separate chemical identity, molecular weight, and raw-material specification.
Drostanolone Enanthate Raw Powder is frequently described online as Masteron Enanthate. That name is widely recognised in the raw-material market, but it should not be confused with a finished or officially branded pharmaceutical product. The historical trade name Masteron is more closely associated with Drostanolone Propionate, whereas “Masteron Enanthate” is commonly used as a market synonym for the longer-chain enanthate ester.
AAS Raw Pharma offers the material as a white or almost white crystalline powder. It is intended for professional organisations that can lawfully acquire, test, store, and work with this type of biologically active substance.
| Specification | Product details |
|---|---|
| Product name | Drostanolone Enanthate Raw Powder |
| Alternative name | Dromostanolone Enanthate |
| Common market name | Masteron Enanthate |
| CAS number | 13425-31-5 |
| Molecular formula | C27H44O3 |
| Molecular weight | Approximately 416.6 g/mol |
| Stated assay | 99.7%, subject to batch documentation |
| Appearance | White or almost white crystalline powder |
| Physical form | Solid powder |
| Product standard | Enterprise Standard |
| Material category | Steroidal research and manufacturing raw material |
| Supply capacity | Up to 100 kg per month, subject to availability |
| Packaging | Sealed foil bag, protective container, or bulk packaging |
| Documentation | Batch-specific documents available on request, where applicable |
| Intended users | Qualified laboratories, research organisations, and authorised manufacturers |
| Direct use | Not intended for direct human or veterinary use |
The listed specifications describe the commercial product generally. Final acceptance should always be based on the documentation and analytical results associated with the particular batch being supplied.
Authoritative reference suppliers identify Drostanolone Enanthate as CAS 13425-31-5, with the formula C27H44O3 and a molecular weight of approximately 416.6 g/mol.
Drostanolone Enanthate Raw Powder is an esterified form of drostanolone. The parent compound belongs to a group of synthetic steroidal substances structurally related to dihydrotestosterone. Esterification with enanthic acid produces a chemically distinct substance from the non-esterified parent compound and from shorter-chain esters such as Drostanolone Propionate.
The compound has been discussed in scientific, forensic, analytical, and controlled-substance contexts. In the United States, for example, a prominent reference-material supplier identifies it as a restricted Schedule III product. Its precise legal classification differs internationally, which makes destination-specific compliance checks essential.
Drostanolone Enanthate Raw Powder should not be mistaken for a sterile solution. Turning an active raw material into a regulated pharmaceutical preparation requires validated facilities, qualified personnel, appropriate excipients, sterility controls, analytical release testing, regulatory authorisation, and compliance with applicable manufacturing standards.
Purchasers may encounter this compound under several names, including:
These names may be used in catalogues, laboratory databases, commercial enquiries, or technical documentation. For accurate identification, buyers should rely on the full chemical name, CAS number, molecular formula, and batch documentation rather than a market nickname alone.
Under the AAS Raw Pharma product specification, Drostanolone Enanthate Powder appears as a white or almost white crystalline powder. Appearance testing can form part of a basic incoming-material inspection, but colour and texture alone cannot confirm identity, assay, purity, or suitability.
A powder with the expected appearance could still contain impurities, another substance, residual solvents, or material with a different assay. Qualified purchasers should therefore use appropriate analytical controls and verify that the package label, batch number, and supporting documents correspond to the material received.
The stated assay for this AAS Raw Pharma product is 99.7%. This percentage should be treated as a batch-dependent analytical specification rather than a universal property of every unit offered under the product name.
A meaningful purity or assay statement should be connected to:
Customers should request the current Certificate of Analysis before ordering when a particular assay threshold is required. A website statement must not replace the purchaser’s incoming inspection, independent verification, or formal release procedures.
Quality evaluation for steroidal raw materials can extend beyond one assay percentage. Depending on the product specification, intended professional application, and testing capability, a batch may be assessed for identity, assay, appearance, impurities, residual solvents, moisture, or related quality characteristics.
Relevant laboratory techniques may include chromatographic, spectroscopic, or mass-based methods. The appropriate test programme and acceptance limits must be established by the purchaser’s qualified technical personnel.
AAS Raw Pharma customers may request the documentation available for a specific batch. The precise tests and results should be confirmed from that batch’s records rather than assumed from a general product-page description.
A Certificate of Analysis, or COA, is a batch-specific document summarising selected tests and results for the supplied material. Depending on availability and the applicable specification, a COA may state:
Before accepting a shipment, the buyer should check that the batch number printed on the packaging matches the batch number on the COA. Where independent confirmation is required, the material should remain appropriately isolated until the customer’s testing and release process is complete.
A Safety Data Sheet may provide information about material identification, handling precautions, storage, accidental exposure, disposal, and transport considerations. It should be reviewed by trained personnel before the package is opened or sampled.
Reference suppliers classify Drostanolone Enanthat raw powder e as a restricted research material and explicitly state that their material is not for personal or veterinary use. A Safety Data Sheet from Cayman Chemical similarly describes its reference material as intended for research rather than human or veterinary diagnostic or therapeutic use.
Customers should request the current documents available for the AAS Raw Pharma batch rather than applying another supplier’s documentation to this product.
Drostanolone Enanthate raw Powder and Drostanolone Propionate share the same parent steroidal compound but contain different ester groups. They are therefore separate chemical substances and should not be treated as interchangeable ingredients.
| Feature | Drostanolone Enanthate | Drostanolone Propionate |
|---|---|---|
| Parent compound | Drostanolone | Drostanolone |
| Ester | Enanthate | Propionate |
| Common market name | Masteron Enanthate | Masteron Propionate |
| Chemical identity | Separate esterified compound | Separate esterified compound |
| CAS number | 13425-31-5 | Different identifier |
| Interchangeable as raw materials | No | No |
The historical name Masteron was associated principally with Drostanolone Propionate. “Masteron Enanthate” is now widely used by raw-material suppliers as a commercial synonym for the enanthate ester. Buyers should specify Drostanolone Enanthate Raw Powder, CAS 13425-31-5, on quotation requests, purchase orders, and internal receiving records.
Subject to local law, customer qualification, and applicable licences, Drostanolone Enanthate raw powder material may be supplied for professional applications such as:
This list does not imply that every use is legal in every location. The receiving organisation is responsible for determining the substance’s regulatory status and establishing a compliant end use.
Proper packaging helps protect Drostanolone Enanthate Raw Powder from environmental exposure, contamination, loss, and damage during transport. Depending on the quantity and approved order requirements, available configurations may include:
Each package should be associated with adequate product and batch identification. The available packaging format depends on quantity, stock, destination rules, and transport requirements.
AAS Raw Pharma does not use false labels, deceptive descriptions, or concealed declarations to evade customs controls. All shipments must be described and handled in accordance with applicable law.
A reference supplier specifies refrigerated storage at 2-8 degrees C for its Drostanolone Enanthate product. Storage conditions can depend on the formulation, packaging, specification, and stability data, so customers should follow the instructions stated on the current AAS Raw Pharma batch documentation rather than relying solely on a generic online recommendation.
General professional storage practices include:
Do not adopt a storage temperature that conflicts with the batch label, COA, Safety Data Sheet, stability data, or regulatory requirements.
Drostanolone Enanthate Raw Powder is a biologically active material and requires professional handling controls. Before working with it, a qualified organisation should perform a risk assessment and establish appropriate containment, personal protective equipment, sampling, cleaning, and disposal procedures.
Recommended precautions include:
This material must not be tasted, swallowed, injected, inhaled deliberately, or applied directly to the body. It should be kept out of reach of children and unauthorised individuals.
AAS Raw Pharma reports a supply capacity of up to 100 kg per month for Drostanolone Enanthate raw Powder, subject to production schedules, inventory, customer approval, legal restrictions, and destination requirements.
Available quantities can vary. Approved customers seeking a commercial quotation should state:
Providing complete enquiry information allows AAS Raw Pharma to assess availability and prepare a more accurate commercial response.
A sample may be available for qualified customers, depending on stock, intended use, destination regulations, and internal approval. Sample availability is not guaranteed and should not be described as “free” unless the specific offer and shipping terms have been confirmed.
A sample is intended to support legitimate supplier qualification or analytical evaluation. Receiving a sample does not remove the customer’s responsibility to verify identity, quality, legal status, and suitability.
AAS Raw Pharma supports qualified B2B and institutional customers seeking high-purity steroidal research and manufacturing raw materials. The service is built around clear specifications, batch-level information, responsible logistics, and responsive commercial assistance.
The listed assay for this Drostanolone Enanthate Raw Powder is 99.7%, subject to confirmation in the documentation associated with the supplied batch.
Direct sourcing can support competitive quotations for approved sample, small-volume, and bulk enquiries. Final pricing depends on quantity, packaging, destination, available inventory, and compliance requirements.
Customers can request available documentation for the current lot, including a COA or other technical information where applicable. Documentation availability should be confirmed before purchase.
Packaging can be selected according to quantity and approved commercial requirements. Options may include sealed foil bags, protective containers, or suitable bulk packaging.
With a reported monthly capacity of up to 100 kg, AAS Raw Pharma can evaluate recurring and bulk purchasing requirements, subject to availability and legal approval.
The sales team can assess courier and freight options for destinations where the material may be lawfully exported, transported, and imported.
Customers can request support concerning order status, batch documents, packaging, and shipment information. Any discrepancy should be reported promptly with the relevant order and batch details.
To request a quotation from AAS Raw Pharma, provide accurate company, product, quantity, destination, and end-use information. Additional verification or compliance documentation may be required before an order can be approved.
A standard enquiry should include:
Submission of an enquiry does not guarantee acceptance. AAS Raw Pharma may decline an order where legal, documentation, identity, destination, transport, or end-use requirements cannot be satisfied.
International delivery may be arranged where the transaction and transport are lawful. The final carrier depends on destination, shipment size, product classification, service availability, and the carrier’s acceptance rules.
Potential delivery providers may include DHL, FedEx, UPS, TNT, EMS, or an approved freight operator. Naming a carrier does not guarantee that it will accept this material for every route.
Customers are responsible for checking:
AAS Raw Pharma does not guarantee customs clearance. A destination appearing within a general sales territory does not mean that Drostanolone Enanthate raw powder may legally be imported there.
The legal classification of Drostanolone Enanthate Raw Powder varies by country. It may be regulated as an anabolic-androgenic steroid, controlled substance, prescription-related material, research chemical, or pharmaceutical raw ingredient.
The buyer must determine whether acquisition requires:
AAS Raw Pharma supplies only for lawful, documented purposes. The company does not support personal steroid use, unauthorised manufacturing, doping, evasion of customs controls, or misleading shipment declarations.
This product page is commercial and technical information for a raw chemical material. It is not medical advice and does not recommend Drostanolone Enanthate raw powder for bodybuilding, muscle building, cutting, athletic performance, hormone therapy, cancer treatment, cholesterol management, or any other personal application.
No dosing or cycle information is included because a raw powder is not a finished pharmaceutical product. Statements such as “400-600 mg per week for men” or “100 mg per week for women” are not appropriate for a bulk ingredient page and could encourage unsafe, unsupervised use.
AAS Raw Pharma does not claim that this raw material is approved to diagnose, treat, cure, or prevent any disease. Any legitimate clinical use of an approved finished medicine must be determined by a licensed healthcare professional and governed by the relevant regulator.
Drostanolone Enanthate Raw Powder is the solid raw form of drostanolone esterified with enanthic acid. It is a bulk chemical material intended for qualified research, analytical, reference, or other legally authorised professional applications.
Masteron Enanthate is a common market name for Drostanolone Enanthate raw powder. However, raw powder sold under this name is not a finished branded medicine.
The historical Masteron trade name is primarily associated with Drostanolone Propionate. The term Masteron Enanthate is commonly used in today’s raw-material market for the enanthate ester.
The CAS number is 13425-31-5.
The molecular formula is C27H44O3.
The molecular weight is approximately 416.6 g/mol. This value is listed by established analytical reference suppliers.
The AAS Raw Pharma specification describes it as a white or almost white crystalline powder. Visual appearance cannot establish chemical identity or purity.
The listed assay is 99.7%, subject to confirmation by the applicable batch documentation.
Available batch documents can be requested before purchase. Customers should confirm the exact documentation supplied with their order.
No. They contain different ester groups and are separate chemical substances. They must not be substituted for one another without appropriate technical and regulatory assessment.
No. Raw powder is not a sterile, formulated, tested, or approved injectable product.
No. It is not intended for injection, ingestion, personal use, self-administration, or veterinary use.
No. Dosage and steroid-cycle guidance is not appropriate for a bulk raw material. Medical decisions must be made by licensed healthcare professionals using lawfully approved products.
A sample may be available to qualified customers, subject to stock, customer verification, intended use, destination regulations, and approval.
AAS Raw Pharma reports a supply capacity of up to 100 kg per month, subject to inventory, production scheduling, compliance review, and destination restrictions.
Possible options include sealed foil bags, protective containers, or approved bulk packaging. The final format depends on order quantity and transport requirements.
Follow the conditions on the batch label and supporting technical documents. Keep the container sealed, protected from light and moisture, and secured against unauthorised access.
International delivery may be considered where export, transport, importation, possession, and intended use are lawful. Customers must verify all destination-country requirements.
No. Customs decisions are outside the supplier’s control, and buyers are responsible for permits, declarations, duties, taxes, and import compliance.
Send AAS Raw Pharma the required quantity, destination, company information, lawful intended use, packaging preference, and required documentation. A quotation can then be prepared subject to availability and compliance review. You can buy Drostanolone Enanthate Raw Powder from us today
| Specification | Product details |
|---|---|
| Product name | Drostanolone Enanthate Powder |
| Alternative name | Dromostanolone Enanthate |
| Common market name | Masteron Enanthate |
| CAS number | 13425-31-5 |
| Molecular formula | C27H44O3 |
| Molecular weight | Approximately 416.6 g/mol |
| Stated assay | 99.7%, subject to batch documentation |
| Appearance | White or almost white crystalline powder |
| Physical form | Solid powder |
| Product standard | Enterprise Standard |
| Material category | Steroidal research and manufacturing raw material |
| Supply capacity | Up to 100 kg per month, subject to availability |
| Packaging | Sealed foil bag, protective container, or bulk packaging |
| Documentation | Batch-specific documents available on request, where applicable |
| Intended users | Qualified laboratories, research organisations, and authorised manufacturers |
| Direct use | Not intended for direct human or veterinary use |
